The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C

Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients

(2013) D. Joshi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

(2013) Rebecca L. Morgan et al.   ANNALS OF INTERNAL MEDICINE

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

(2013) Christophe Hézode et al.   JOURNAL OF HEPATOLOGY

Optimal treatment with telaprevir for chronic HCV infection

(2013) Arun B. Jesudian et al.   LIVER INTERNATIONAL

Optimal treatment with boceprevir for chronic HCV infection

(2013) Benjamin Maasoumy et al.   LIVER INTERNATIONAL

Novel therapies for hepatitis C — one pill fits all?

(2013) Michael P. Manns et al.   NATURE REVIEWS DRUG DISCOVERY

On the fast track towards IFN-free therapy for hepatitis C?

(2013) Heiner Wedemeyer   Nature Reviews Gastroenterology & Hepatology

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

(2013) Benjamin Maasoumy et al.   PLoS One

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

(2012) P. Ramachandran et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

(2012) I. A. Rowe et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Natural history of acute and chronic hepatitis C

(2012) Benjamin Maasoumy et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions

(2012) David Burger et al.   JOURNAL OF HEPATOLOGY

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

(2012) Christoph R. Werner et al.   LIVER TRANSPLANTATION

Rapid Onset of Iatrogenic Adrenal Insufficiency in a Patient with Cystic Fibrosis–Related Liver Disease Treated with Inhaled Corticosteroids and a Moderate CYP3A4 Inhibitor

(2011) Wynton C Hoover et al.   ANNALS OF PHARMACOTHERAPY

A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C

(2011) Lisa I. Backus et al.   Clinical Gastroenterology and Hepatology

Insulin resistance and hepatitis C: an evolving story

(2011) M. Eslam et al.   GUT

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Clinically Significant Adverse Events from a Drug Interaction Between Quetiapine and Atazanavir-Ritonavir in Two Patients

(2009) Todd M Pollack et al.   PHARMACOTHERAPY

Endocrine manifestations of hepatitis C virus infection

(2008) Alessandro Antonelli et al.   Nature clinical practice. Endocrinology & metabolism